期刊文献+

基质金属蛋白酶-9基因-1562C/T多态性与川崎病冠脉损害及丙种球蛋白耐药的关系 被引量:5

Relationship of Matrix Metalloproteinase-9(MMP-9) gene-1562 C/T Polymorphism,Coronary Artery Lesions(CAL) and Intravenous Immunoglobulin Treatment(IVIG) Resistance in Children with Kawasaki Disease
下载PDF
导出
摘要 目的研究基质金属蛋白酶-9(MMP-9)基因启动子区-1562 C/T多态性与川崎病(KD)冠状动脉损害(CAL)及与丙种球蛋白(IVIG)耐药的关系。方法收集2010年3月~2012年2月期间确诊KD的住院患儿资料,共124例,其中男性78例,女性46例,平均年龄25.8个月(4个月~67个月)。根据病程中心脏彩超检查的冠脉情况,将124例患儿分为CAL组(21例)和无CAL组(103例)。根据患儿对IVIG的反应,将124例患儿分为IVIG耐药组(14例)和IVIG敏感组(110例)。检测并分析所有KD患儿的MMP-9-1562 C/T基因型频率及等位基因频率,研究其与CAL及IVIG耐药的关系。结果 CAL组中CC/CT基因型频率CC为66.7%,CT为33.3%,与无CAL组(CC为88.3%,CT为11.7%)比较差异有统计学意义(χ2=6.321,P=0.020)。CAL组C/T等位基因频率为C为83.3%,T为16.7%,与无CAL组(C为94.2%,T为5.8%)比较差异有统计学意义(χ2=5.796,P=0.025),并且Logistic回归分析示1562T等位基因是KD患儿发生CAL的危险因素(χ2=5.756,P=0.016,OR=3.792)。IVIG耐药组与IVIG敏感组中MMP-9-1562 CC/CT基因型频率及C/T等位基因频率均无显著统计学意义。结论MMP-9基因-1562C/T多态性与CAL有关,-1562T等位基因加大了KD患儿发生CAL的风险。-1562T等位基因与KD患儿IVIG耐药无明显关系。 Objective To investigate the relationship of matrix metalloproteinase - 9 ( MMP - 9 ) gene - 1562 C/T polymorphism, coronary artery lesions (CAL) and intravenous immunoglobulin treatment (IVIG) resistance in children with Kawasaki disease (KD). Methods Totally 124 pediatric cases of KD (78 boys and 46 girls), the average age was 25.8 months (4 - 67 months). These cases ac- cording to the echocardiography results were divided into CAL group (21 cases) and non -CAL group (103 cases) ; secondary according to their responses to IVIG into resistance group (14 cases) and IVIG responsive group (110 cases). Promoter 1562 C/T gene polymor- phism of MMP-9 were tested in all of these cases. The relationship of MMP-9 gene- 1562 C/T polymorphism, CAL and IVIG resist- ance were analyzed. Results The results of genetic polymorphism analysis showed that the frequency of CT genotype (33.3%) in CAL group was significantly higher than that ( 11.7% ) in non - CAL group (X2 = 6. 321 ,P = 0. 020). The frequency of T allele ( 16.7% ) in CAL group was significantly higher than that (5.8%) in non - CAL group (X2 = 5. 796 ,P = 0. 025 ). The cases carrying the - 1562T al- lele were even more easily developing into CAL (X2 = 5. 756 ,P = 0. 016, OR = 3. 792 ). The frequency of CC/CT genotype or C/T allele showed no significant difference between IVIG resistance group and IVIG responsive group. Conclusion The genetic polymorphism in MMP - 9 gene - 1562C/T is associated to CAL in children with KD. The T allele is a risk factor of CAL. Due to the frequency of CC/CT showed above there is no significant association between T allele and IV1G resistance in KD.
出处 《医学研究杂志》 2013年第4期136-139,共4页 Journal of Medical Research
基金 温州市科技局基金资助项目(Y20080162)
关键词 基质金属蛋白酶-9 川崎病 基因多态性 Metalloproteinase - 9 Gene polymorphism Kawasaki disease
  • 相关文献

参考文献11

  • 1Yellen ES, Gauvreau K, Takahashi M, et al. Performance of 201M A- merican Heart Association recommendations for treatment of Kawasaki disease [ J ]. Pediatrics, 2010,125 (2) : e234 - e241.
  • 2Kim HK, Oh J, Hong YM, Sohn S. Parameters to guide retreatment after initial intravenous immunoglohulin therapy in kawasaki disease [J]. Korean Circ J,2011,41 (7) :379 -384.
  • 3魏洪平,吴敏,朱红枫.川崎病易感基因研究进展[J].实用儿科临床杂志,2008,23(9):705-707. 被引量:13
  • 4Xu J, Zhu D, Sonoda S, et al. Over - expression of BMP4 inhibits ex- perimental choroidal neovaseularization by modulating VEGF and MMP-9[J].Angiogenesis, 2012,15(2) :213 -227.
  • 5Chiang IT, Liu YC, Wang WH, et al. Sorafenib inhibits TPA - in- duced MMP-9 and VEGF expression via suppression of ERK/NF- KB pathway in hepatocellular carcinoma cells [ J ]. In Vivo, 2012,26 (4) :671 -68l.
  • 6Xu HM, Zhao Y, Zhang XM, et al. Polymorphisms in MMP - 9 and TIMP- 2 in Chinese patients with varicose veins[ J]. J Surg Res, 2011,168 ( 1 ) :e143 - e148.
  • 7Vijayalakshmi D, Dhandapani R, Jayaveni S, et al. In vitro anti in- flammatory activity of Aloe vera by down regulation of MMP - 9 in pe- ripheral blood mononuclear cells [ J]. J Ethnopharmacol, 2012, 141 ( 1 ) :542 - 546.
  • 8Park JA, Shin KS, Kim YW. Polymorphism of matrix mctalloprotein- ase - 3 promoter gent as a risk factor for coronary artery lesions in Ka- wasaki disease[J]. J Korean Med Sci,2005,20(4) :607 -611.
  • 9赵乃琤,刘倩琦,秦玉明,刘飞,王大为.基质金属蛋白酶-9基因C1562T多态性与川崎病冠状动脉损伤的关系[J].实用儿科临床杂志,2010,25(9):637-638. 被引量:1
  • 10Weng KP, Hsieh KS, Ho TY, et al. IL - 1B polymorphism in associ- ation with initial intravenous immunoglobulin treatment failure in Tai- wanese children with Kawasaki disease[ J]. Cire J,2010,74 ( 3 ) :544 - 551.

二级参考文献28

共引文献12

同被引文献89

  • 1魏莉,徐盈.基质金属蛋白酶9在老年肺癌中的表达及临床意义[J].中国老年学杂志,2014,34(1):89-90. 被引量:8
  • 2杨世伟,秦玉明,曹黎明,王大为.川崎病伴冠状动脉瘤、休克和多脏器功能损伤一例[J].中华儿科杂志,2006,44(12):917-917. 被引量:4
  • 3杜忠东,贾立群,张永兰,王玉,林瑶,刘冲.血管超声检测川崎病合并体循环动脉瘤的研究[J].中华儿科杂志,2007,45(5):395-396. 被引量:5
  • 4胡亚美,江载芬.诸福棠实用儿科学[M].北京:人民卫生出版社,2005.
  • 5Kanegaye JT, Wilder MS, Molkara D, et al. Recognition of a Ka- wasaki disease shock syndrome[ J]. Pediatrics,2009(123) :e783.
  • 6Yim D, Ramsay J, Kothari D, et al. Coronary artery dilatation in toxic shock-like syndrome: the Kawasaki disease shock syndrome [J]. Pediatr Cardiol,2010(31) :1232.
  • 7Onder Doksz. Kawasaki disease shock syndrome: a severe form of Kawasaki disease[J]. Turkish Journal of Pediatrics,20!3(319) :321.
  • 8Chen IS, Chi H. Clinical manifestations of Kawasaki disease shock syndrome: A case-control study [ J ]. Journal of Microbiology, Immu- nology and Infection,2013(5) :1-8.
  • 9Lin MT, Fu C M, Muang S K,et al. Population-based Study Of Ka- wasaki Disease shock syndrome in Taiwan [ J ]. The Pediatric Infec- tious Disease journal ,2013 (32) :12.
  • 10Gatterre P, Ouallaa M, Duple L, et al. Kawasaki disease: an unex- pected etiology of shock and multiple organ dysfunction syndrome [ J]. Intensive Care Med,2012 (38) :872.

引证文献5

二级引证文献12

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部